Global Hospital-acquired Disease Testing Market 2015-2019

01. Executive Summary
02. List of Abbreviations
03. Scope of the Report
03.1 Market Overview
03.2 Product Offerings
04. Market Research Methodology
04.1 Market Research Process
04.2 Research Methodology
05. Introduction
06. Market Landscape
06.1 Market Overview
06.2 Market Size and Forecast
06.3 Five Forces Analysis
07. Hospital Acquired Infections/Hospital Acquired Diseases
07.1 Background
07.1.1 Symptoms, Prevention, Testing, and Diagnosis for Hospital-Acquired Infections
07.2 Incidence and Prevalence of HAI
07.2.1 Developed Nations
07.2.2 Low and Middle-income Nations
08. Market Segmentation by Product
08.1 Global UTI Testing Market
08.1.1 Market Size and Forecast
08.2 Global SSI Testing Market
08.2.1 Market Size and Forecast
08.3 Global Pneumococcal Infections Testing Market
08.3.1 Market Size and Forecast
08.4 Global Bloodstream Infections Testing Market
08.4.1 Market Size and Forecast
08.5 Global MRSA Testing Market
08.5.1 Market Size and Forecast
09. Geographical Segmentation
09.1 Hospital Acquired Disease Testing Market in Americas
09.1.1 Market Size and Forecast
09.2 Hospital Acquired Disease Market in EMEA
09.2.1 Market Size and Forecast
09.3 Hospital Acquired Disease Market in APAC
09.3.1 Market Size and Forecast
10. Buying Criteria
11. Market Growth Drivers
12. Drivers and their Impact
13. Market Challenges
14. Impact of Drivers and Challenges
15. Market Trends
16. Trends and their Impact
17. Vendor Landscape
17.1 Competitive Scenario
17.1.1 Key News
17.1.2 Mergers and Acquisitions
17.2 Market Share Analysis 2014
17.2.1 Abbott
17.2.2 BD
17.2.3 bioMerieux
17.2.4 Roche Diagnostics
17.3 Other Prominent Vendors
18. Key Vendor Analysis
18.1 Abbott Laboratories Inc.
18.1.1 Key Facts
18.1.2 Business Description
18.1.3 Business Segmentation
18.1.4 Business Strategy
18.1.5 Revenue by Business Segmentation
18.1.6 Revenue Comparison 2011 and 2012
18.1.7 Revenue by Geographical Segmentation
18.1.8 Key Information
18.1.9 SWOT Analysis
18.2 Becton, Dickinson and Co.
18.2.1 Key Facts
18.2.2 Business Description
18.2.3 Business Segmentation
18.2.4 Revenue Segmentation by Business
18.2.5 Segmental Revenue Comparison - 2013 and 2012
18.2.6 Revenue Segmentation by Geography
18.2.7 Business Strategy
18.2.8 Key Developments
18.2.9 SWOT Analysis
18.3 bioMeriux
18.3.1 Key Facts
18.3.2 Business Overview
18.3.3 Business Segmentation by Revenue 2013
18.3.4 Geographical Segmentation by Revenue 2013
18.3.5 Business Strategy
18.3.6 Recent Developments
18.3.7 SWOT Analysis
18.4 Roche Diagnostics
18.4.1 Key Facts
18.4.2 Business Overview
18.4.3 Business Segmentation by Revenue 2014
18.4.4 Business Segmentation by Revenue 2013 and 2014
18.4.5 Geographical Segmentation by Revenue 2014
18.4.6 Business Strategy
18.4.7 Recent Developments
18.4.8 SWOT Analysis
19. Other Reports in this Series